New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Indiva Limited
NDVAF
Shape
US Flag

PNK

Unprofitable

Unprofitable

4M

Drug Manufacturers - Specialty & Generic

Next Earning date - 24 Oct 2024

4M

Drug Manufacturers - Specialty & Generic

Next Earning date - 24 Oct 2024

0.02USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

100%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

78%

Quote Panel

Shape
Updated October 24, 2024
1W 0.00 % 1M 0.00 % 3M 0.00 % 1Y -47.50 %

Key Metrics

Shape
  • Market Cap

    4.25M


  • Shares Outstanding

    202.55M


  • Share in Float

    118.18M


  • Dividende

    0


  • Earning Date

    24 Oct 2024


  • Price Target

    0.021


  • Average Volume


  • Beta

    1.079


  • Range

    0.021-0.095


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.indiva.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.16x

P/S Ratio

-4.28x

P/B Ratio

-17.1

Debt/Equity

-11.8%

Net Margin

$-0.0

EPS

How NDVAF compares to sector?

P/E Ratio

Relative Strength

Shape

NDVAF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$45M

Shape380%

2025-Revenue

0

$21M

Shape-5795%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q4.21

arrow
arrow

N/A

NA
vs NA

Q1.22

arrow
arrow

N/A

-0.02
vs -0.02

Q2.22

arrow
arrow

N/A

-0.02
vs -0.04

Q3.22

arrow
arrow

N/A

-0.02
vs -0.05

Q4.22

arrow
arrow

N/A

NA
vs NA

Q1.23

arrow
arrow

N/A

-0.01
vs -0.02

Q2.23

arrow
arrow

N/A

-0.01
vs -0.02

Q3.23

arrow
arrow

N/A

-0.00
vs -0.02

Q4.23

arrow
arrow

N/A

NA
vs NA

Q1.24

arrow
arrow

N/A

-0.01
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

-10%

8.1M  vs 9.1M

Q3.22

arrow
arrow

+5%

8.1M  vs 7.7M

Q4.22

arrow
arrow

-2%

9.3M  vs 9.5M

Q1.23

arrow
arrow

+5%

9.4M  vs 8.9M

Q2.23

arrow
arrow

-8%

7.5M  vs 8.1M

Q3.23

arrow
arrow

+21%

9.8M  vs 8.1M

Q4.23

arrow
arrow

+17%

10.9M  vs 9.3M

Q1.24

arrow
arrow

-1%

9.3M  vs 9.4M

Q2.24

arrow
arrow

+38%

10.4M  vs 7.5M

Q3.24

arrow
arrow

+15%

11.2M  vs 9.8M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-38%

-0.38
vs -0.34

Q3.22

arrow
arrow

-58%

-0.58
vs -0.38

Q4.22

arrow
arrow

-130%

-1.30
vs -0.58

Q1.23

arrow
arrow

+6691%

66.91
vs -1.30

Q2.23

arrow
arrow

-80%

-0.80
vs 66.91

Q3.23

arrow
arrow

-243%

-2.43
vs -0.80

Q4.23

arrow
arrow

+224%

2.24
vs -2.43

Q1.24

arrow
arrow

+138%

1.38
vs 2.24

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News